Published in JAMA on January 26, 2005
Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care (2009) 5.41
Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med (2009) 3.92
Hyperpolarized 13C allows a direct measure of flux through a single enzyme-catalyzed step by NMR. Proc Natl Acad Sci U S A (2007) 3.15
Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest (2013) 2.83
Signaling pathways in ischemic preconditioning. Heart Fail Rev (2007) 2.26
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev (2007) 2.14
Design and implementation of GRIP: a computerized glucose control system at a surgical intensive care unit. BMC Med Inform Decis Mak (2005) 1.76
The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant (2009) 1.56
Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol (2010) 1.55
Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. Am J Med (2011) 1.48
Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points. Diab Vasc Dis Res (2008) 1.48
Relation between the global burden of disease and randomized clinical trials conducted in Latin America published in the five leading medical journals. PLoS One (2008) 1.09
Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol (2016) 1.08
Hyperglycaemia in critically ill patients: marker or mediator of mortality? Crit Care (2006) 1.01
Insulin therapy in critically ill patients. Vasc Health Risk Manag (2010) 1.00
Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial. JAMA (2005) 0.99
Reperfusion injury as a therapeutic challenge in patients with acute myocardial infarction. Heart Fail Rev (2007) 0.95
Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium. Pharmacol Ther (2014) 0.95
Persistent hyperglycemia is an independent predictor of outcome in acute myocardial infarction. Cardiovasc Diabetol (2007) 0.92
Postconditioning signalling in the heart: mechanisms and translatability. Br J Pharmacol (2014) 0.88
Cardioprotection and pharmacological therapies in acute myocardial infarction: Challenges in the current era. World J Cardiol (2014) 0.87
Early increase in blood glucose in patients resuscitated from out-of-hospital ventricular fibrillation predicts poor outcome. Diabetes Care (2012) 0.87
Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial. JAMA (2005) 0.87
Hyperglycemia and perioperative glucose management. Curr Pharm Des (2012) 0.87
Periprocedural glycemic control in patients with diabetes mellitus undergoing coronary angiography with possible percutaneous coronary intervention. Am J Cardiol (2014) 0.86
The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism. Br J Pharmacol (2015) 0.85
Effect of glucose-insulin-potassium infusion on mortality in critical care settings: a systematic review and meta-analysis. J Clin Pharmacol (2009) 0.84
Novel adjunctive treatments of myocardial infarction. World J Cardiol (2014) 0.84
Remote conditioning the heart overview: translatability and mechanism. Br J Pharmacol (2014) 0.84
Nonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon. Circ Res (2014) 0.84
Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction. PLoS One (2012) 0.84
Glycemic Control during Coronary Artery Bypass Graft Surgery. ISRN Cardiol (2012) 0.84
The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616]. BMC Med (2005) 0.83
Protection of the ischemic myocardium during the reperfusion: between hope and reality. Am J Cardiovasc Dis (2012) 0.83
Therapeutic strategies for high-dose vasopressor-dependent shock. Crit Care Res Pract (2013) 0.82
Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus. Cardiovasc Diabetol (2015) 0.82
Impact of anaerobic glycolysis and oxidative substrate selection on contractile function and mechanical efficiency during moderate severity ischemia. Am J Physiol Heart Circ Physiol (2008) 0.82
Glucose and potassium derangements by glucose-insulin-potassium infusion in acute myocardial infarction. Neth Heart J (2006) 0.82
Factors related to in-hospital heart failure are very different for unstable angina and non-ST elevation myocardial infarction. Heart Vessels (2009) 0.82
Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipients. Bone Marrow Transplant (2016) 0.81
Adjuvant cardioprotection in cardiac surgery: update. Biomed Res Int (2014) 0.81
An examination of effect estimation in factorial and standardly-tailored designs. Clin Trials (2008) 0.81
Cardiovascular disease, neuropathy, and retinopathy. Diabetes Care (2009) 0.81
Strict glucose control in the critically ill. BMJ (2006) 0.81
How to best manage glycemia and non-glycemia during the time of acute myocardial infarction. Diabetes Technol Ther (2012) 0.80
Effects of acute hyperglycaemia on cardiovascular homeostasis: does a spoonful of sugar make the flow-mediated dilatation go down? J Thorac Dis (2015) 0.80
Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial. Trials (2011) 0.80
Data monitoring committees for pragmatic clinical trials. Clin Trials (2015) 0.79
The role of insulin therapy and glucose normalisation in patients with acute coronary syndrome. Neth Heart J (2011) 0.79
Glycemic variability and glycemic control in the acutely ill cardiac patient. Heart Fail Clin (2012) 0.79
Heart failure and loss of metabolic control. J Cardiovasc Pharmacol (2014) 0.79
Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial. JAMA (2005) 0.79
Impact of admission blood glucose levels on prognosis of elderly patients with ST elevation myocardial infarction treated by primary percutaneous coronary intervention. J Geriatr Cardiol (2013) 0.78
Conditioning the heart to prevent myocardial reperfusion injury during PPCI. Eur Heart J Acute Cardiovasc Care (2012) 0.78
Glucose-insulin-potassium therapy in patients with STEMI. JAMA (2008) 0.78
A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction. Exp Clin Cardiol (2010) 0.77
Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study. BMC Endocr Disord (2011) 0.77
Piloting a novel algorithm for glucose control in the coronary care unit: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) trial. Diabetes Care (2011) 0.77
Admission glucose and risk of early death in non-diabetic patients with ST-segment elevation myocardial infarction: a meta-analysis. Med Sci Monit (2015) 0.77
Refractory hyperglycaemia induced by glucose-insulin-potassium infusion in acute myocardial infarction. Neth Heart J (2006) 0.77
Glucose-insulin-potassium solution protects ventricular myocytes of neonatal rat in an in vitro coverslip ischemia/reperfusion model. Korean Circ J (2015) 0.76
Effect of perioperative glucose-insulin-potassium infusions on mortality and atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis. Can J Cardiol (2010) 0.76
A glucose-insulin-potassium infusion did not reduce mortality, cardiac arrest, or cardiogenic shock after acute MI. ACP J Club (2005) 0.76
The Worsening Profile of Alcoholic Hepatitis in the United States. Alcohol Clin Exp Res (2016) 0.76
[Diabetes mellitus and coronary artery disease--a high risk combination]. Clin Res Cardiol (2006) 0.76
Metformin treatment in hyperglycemic critically ill patients: another challenge on the control of adverse outcomes. Iran J Pharm Res (2011) 0.76
Simple principles of clinical trials remain powerful. JAMA (2005) 0.76
Does tight glucose control prevent myocardial injury and inflammation? J Extra Corpor Technol (2011) 0.76
Ultra-acute increase in blood glucose during prehospital phase is associated with worse short-term and long-term survival in ST-elevation myocardial infarction. Scand J Trauma Resusc Emerg Med (2014) 0.75
Influence on prognosis and prevalence of stress hyperglycemia in a cohort of patients with acute coronary syndrome. Rev Bras Ter Intensiva (2012) 0.75
A predictive model to identify patients with suspected acute coronary syndromes at high risk of cardiac arrest or in-hospital mortality: An IMMEDIATE Trial sub-study(,,.) Int J Cardiol Heart Vasc (2015) 0.75
C-Reactive protein reactions to glucose-insulin-potassium infusion and relations to infarct size in patients with acute coronary syndromes. BMC Cardiovasc Disord (2015) 0.75
GIK in acute myocardial infarction: lessons from CREATE-ECLA, GIPS II and DIGAMI 2. Neth Heart J (2005) 0.75
A quantitative analysis of the effect of glucose-insulin-potassium in acute myocardial infarction. Neth Heart J (2006) 0.75
Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study. J Diabetes Res (2015) 0.75
Glucose-insulin-potassium therapy in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord (2014) 0.75
Guidelines for Perioperative Management of the Diabetic Patient. Surg Res Pract (2015) 0.75
Glucose-insulin-potassium therapy in patients with STEMI. JAMA (2008) 0.75
Glucose-insulin-potassium correlates with hemodynamic improvement in patients with septic myocardial dysfunction. J Thorac Dis (2016) 0.75
Managing hyperglycaemia in patients with type 2 diabetes and known cardiovascular disease. J R Soc Med (2012) 0.75
Molecular mechanisms of hyperglycemia and cardiovascular-related events in critically ill patients: rationale for the clinical benefits of insulin therapy. Clin Epidemiol (2010) 0.75
The effect of insulin on the heart: Part 2: Effects on function during and post myocardial ischaemia. Neth Heart J (2010) 0.75
Admission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabetics. Cardiol Res Pract (2012) 0.75
High-dose glucose-insulin-potassium has hemodynamic benefits and can improve cardiac remodeling in acute myocardial infarction treated with primary percutaneous coronary intervention: From a randomized controlled study. J Cardiovasc Dis Res (2010) 0.75
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 42.12
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Genetics of gene expression and its effect on disease. Nature (2008) 21.35
Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04
Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med (2008) 19.76
Mapping the genetic architecture of gene expression in human liver. PLoS Biol (2008) 19.44
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med (1991) 16.19
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet (2008) 13.34
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet (2008) 13.15
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19
Variations in DNA elucidate molecular networks that cause disease. Nature (2008) 12.04
Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med (2006) 11.72
Universal definition of myocardial infarction. Circulation (2007) 11.69
Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med (2009) 11.49
An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet (2005) 11.40
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med (2012) 10.09
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet (2003) 9.98
Apixaban in patients with atrial fibrillation. N Engl J Med (2011) 9.97
Effect of ramipril on the incidence of diabetes. N Engl J Med (2006) 9.69
Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet (2011) 8.49
Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med (2015) 7.83
Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med (2014) 7.54
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA (2005) 7.35
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet (2010) 7.08
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA (2005) 6.81
Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med (2014) 6.65
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation (2011) 6.48
Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med (2012) 6.42
Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA (2007) 6.38
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med (2012) 6.16
Aspirin in patients undergoing noncardiac surgery. N Engl J Med (2014) 6.10
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med (2010) 6.05
Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet (2006) 5.85
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation (2002) 5.79
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA (2006) 5.74
MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol Cell (2007) 5.67
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy. N Engl J Med (2015) 5.31
Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet (2008) 5.27
Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med (2006) 5.24
Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA (2013) 5.19
Use of ramipril in preventing stroke: double blind randomised trial. BMJ (2002) 4.91
Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med (2014) 4.88
Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J (2007) 4.88